...
search icon
chro-img

Chromocell Therapeutics Corporation, Common Stock

CHRO

ASQ

$0.965

+$0.06

(6.65%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.18M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
69.29K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.45 L
$6 H
$0.965

About Chromocell Therapeutics Corporation, Common Stock

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCHROSectorS&P500
1-Week Return12.82%0.49%-1.93%
1-Month Return45.57%-3.1%-3.69%
3-Month Return64.1%-8.59%0.82%
6-Month Return-34.6%-4.57%3.51%
1-Year Return-81.2%-0.94%21.91%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue199.93K---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue138.59K209.05K391.73K2.58M[{"date":"2020-12-31","value":5.37,"profit":true},{"date":"2021-12-31","value":8.1,"profit":true},{"date":"2022-12-31","value":15.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit61.35K(209.05K)(391.73K)(2.58M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-340.75,"profit":false},{"date":"2022-12-31","value":-638.53,"profit":false},{"date":"2023-12-31","value":-4204.5,"profit":false}]
Gross Margin30.68%---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses1.55M839.00K2.32M6.86M[{"date":"2020-12-31","value":22.64,"profit":true},{"date":"2021-12-31","value":12.23,"profit":true},{"date":"2022-12-31","value":33.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(1.35M)(839.00K)(2.32M)(6.86M)[{"date":"2020-12-31","value":-135387000,"profit":false},{"date":"2021-12-31","value":-83900000,"profit":false},{"date":"2022-12-31","value":-231816000,"profit":false},{"date":"2023-12-31","value":-686228400,"profit":false}]
Total Non-Operating Income/Expense691.61K243.36K(280.86K)(1.04M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.19,"profit":true},{"date":"2022-12-31","value":-40.61,"profit":false},{"date":"2023-12-31","value":-149.94,"profit":false}]
Pre-Tax Income(660.58K)(595.39K)(2.46M)(7.38M)[{"date":"2020-12-31","value":-66058400,"profit":false},{"date":"2021-12-31","value":-59538700,"profit":false},{"date":"2022-12-31","value":-245858900,"profit":false},{"date":"2023-12-31","value":-738079300,"profit":false}]
Income Taxes(1.35M)(839.00K)(690.45K)(6.86M)[{"date":"2020-12-31","value":-135386700,"profit":false},{"date":"2021-12-31","value":-83899600,"profit":false},{"date":"2022-12-31","value":-69045200,"profit":false},{"date":"2023-12-31","value":-686228400,"profit":false}]
Income After Taxes693.28K243.61K(1.77M)(518.51K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.14,"profit":true},{"date":"2022-12-31","value":-255.04,"profit":false},{"date":"2023-12-31","value":-74.79,"profit":false}]
Income From Continuous Operations(660.58K)(595.39K)(2.46M)(7.38M)[{"date":"2020-12-31","value":-66058400,"profit":false},{"date":"2021-12-31","value":-59538700,"profit":false},{"date":"2022-12-31","value":-245858900,"profit":false},{"date":"2023-12-31","value":-738079300,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(660.58K)(595.39K)(2.46M)(7.38M)[{"date":"2020-12-31","value":-66058400,"profit":false},{"date":"2021-12-31","value":-59538700,"profit":false},{"date":"2022-12-31","value":-245858900,"profit":false},{"date":"2023-12-31","value":-738079300,"profit":false}]
EPS (Diluted)----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CHRO
Cash Ratio 0.35
Current Ratio 0.60
Quick Ratio 0.61

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CHRO
ROA (LTM) -412.80%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CHRO
Debt Ratio Lower is generally better. Negative is bad. 1.67
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.67

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CHRO
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.11
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Chromocell Therapeutics Corporation share price today?

Chromocell Therapeutics Corporation (CHRO) share price today is $0.965

Can Indians buy Chromocell Therapeutics Corporation shares?

Yes, Indians can buy shares of Chromocell Therapeutics Corporation (CHRO) on Vested. To buy Chromocell Therapeutics Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CHRO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Chromocell Therapeutics Corporation be purchased?

Yes, you can purchase fractional shares of Chromocell Therapeutics Corporation (CHRO) via the Vested app. You can start investing in Chromocell Therapeutics Corporation (CHRO) with a minimum investment of $1.

How to invest in Chromocell Therapeutics Corporation shares from India?

You can invest in shares of Chromocell Therapeutics Corporation (CHRO) via Vested in three simple steps:

  • Click on Sign Up or Invest in CHRO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Chromocell Therapeutics Corporation shares
What is Chromocell Therapeutics Corporation 52-week high and low stock price?

The 52-week high price of Chromocell Therapeutics Corporation (CHRO) is $6. The 52-week low price of Chromocell Therapeutics Corporation (CHRO) is $0.45.

What is Chromocell Therapeutics Corporation price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Chromocell Therapeutics Corporation (CHRO) is

What is Chromocell Therapeutics Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Chromocell Therapeutics Corporation (CHRO) is 4.11

What is Chromocell Therapeutics Corporation dividend yield?

The dividend yield of Chromocell Therapeutics Corporation (CHRO) is 0.00%

What is the Market Cap of Chromocell Therapeutics Corporation?

The market capitalization of Chromocell Therapeutics Corporation (CHRO) is $5.18M

What is Chromocell Therapeutics Corporation’s stock symbol?

The stock symbol (or ticker) of Chromocell Therapeutics Corporation is CHRO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top